Ladiratuzumab Vedotin
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ladiratuzumab Vedotin, covering 2025-03-10 to 2025-06-17. Get the full timeline:
Most recent: Clinical Trial Update: Expanded Access Use of Ladiratuzumab Vedotin in Advanced Solid Tumors